Integra Lifesciences's total assets for Q1 2025 were $4.05B, an increase of 0.38% from the previous quarter. IART total liabilities were $2.53B for the fiscal quarter, a 1.46% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.